ERβ is expressed and demonstrated to exert anti-proliferative effects in different preclinical in vitro and in vivo models of human cancers, for example, breast, colon, prostate, lymphoma, and pleural mesothelioma [13, 15, 17–25]. Here, ESR2 is linked to cancer.